State AZ
Clinical Trials in Arizona
Arizona is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Arizona and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 256 actively recruiting studies with Arizona sites out of 256 registered in total. The busiest research areas in Arizona are Malignant Solid Neoplasm, Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia. Leading sponsors running trials in the state include Mayo Clinic, AstraZeneca, Eli Lilly and Company. By stage, Arizona trials break down as Phase 1 (46), Phase 2 (78), Phase 3 (70), Phase 4 (5).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Arizona
Frequently Asked Questions — Clinical Trials in Arizona
How many clinical trials are currently recruiting in Arizona?
ClinicalMetric currently tracks 256 actively recruiting clinical trials with at least one location in Arizona. The total number of registered studies—including active but not currently enrolling trials—is 256. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Arizona?
Arizona hosts clinical trials across a broad range of medical conditions, including Malignant Solid Neoplasm, Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Arizona serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Arizona?
To join a clinical trial in Arizona, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Arizona maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Arizona
NCT07601074 Phase 2
Recruiting
A Study of the Preliminary Efficacy of DARE-HPV to Treat High-risk Persistent Hu...
Condition
Human Papilloma Virus (HPV)
Enrollment
118 pts
Location
United States
Sponsor
Daré Bioscience, Inc.
NCT06136650 Phase 3
Recruiting
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Age...
Condition
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Enrollment
1,314 pts
Location
United States, Australia, Brazil
Sponsor
Merck Sharp & Dohme LLC
NCT07284784 Phase 2, Phase 3
Recruiting
A Study of Buntanetap in Participants With PD
Condition
Parkinson's Disease (PD)
Enrollment
500 pts
Location
United States
Sponsor
Annovis Bio Inc.
NCT07211958 Phase 3
Recruiting
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed...
Condition
Acute Myeloid Leukemias
Enrollment
468 pts
Location
United States, Australia, Austria
Sponsor
Syndax Pharmaceuticals
NCT06911138 N/A
Recruiting
Treating Complex Grammar Knowledge Deficits in School-Age Children With Developm...
Condition
Developmental Language Disorders
Enrollment
150 pts
Location
United States
Sponsor
Ohio University
NCT07547215 N/A
Recruiting
Post-Market Clinical Study Using TRAQ™ for Minimally Invasive Posterior Sacroili...
Condition
Sacroiliac Joint Dysfunction
Enrollment
100 pts
Location
United States
Sponsor
PainTEQ, LLC
NCT07559474 Phase 1
Recruiting
A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administere...
Condition
Hepatic Insufficiency
Enrollment
16 pts
Location
United States
Sponsor
Incyte Corporation
NCT05806515 Phase 2
Recruiting
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cance...
Condition
Prostate Adenocarcinoma
Enrollment
44 pts
Location
United States
Sponsor
SWOG Cancer Research Network
NCT06585774 Phase 3
Recruiting
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chro...
Condition
Chronic Graft-versus-host-disease
Enrollment
240 pts
Location
United States, Australia, Austria
Sponsor
Incyte Corporation
NCT07081646 Phase 1, Phase 2
Recruiting
A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants...
Condition
Relapsed AL Amyloidosis
Enrollment
91 pts
Location
United States, Canada, United Kingdom
Sponsor
Alexion Pharmaceuticals, Inc.
NCT06908356 Phase 2
Recruiting
An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults Wi...
Condition
Focal Onset Seizure
Enrollment
50 pts
Location
United States, Australia, Spain
Sponsor
Praxis Precision Medicines
NCT06643741 N/A
Recruiting
Non-Invasive Preeclampsia Screening and Biobank
Condition
Preeclampsia (PE)
Enrollment
6,550 pts
Location
United States
Sponsor
Sequenom, Inc.
NCT04871542 N/A
Recruiting
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Condition
Malignant Solid Neoplasm
Enrollment
2,062 pts
Location
United States, Chile, Guam
Sponsor
SWOG Cancer Research Network
NCT07583641 Phase 2
Recruiting
A Study to Learn About How Well the Medicine Efgartigimod Works to Treat Autoimm...
Condition
Autoimmune Encephalitis (AE)
Enrollment
170 pts
Location
United States
Sponsor
argenx
NCT03954431 N/A
Recruiting
High-Resolution Lower Dose Dedicated Breast Computed Tomography (CT)
Condition
Breast Cancer
Enrollment
600 pts
Location
United States
Sponsor
University of Arizona
NCT07125729 N/A
Recruiting
Minimal Residual Disease Testing for the Early Detection of Cancer Recurrence in...
Condition
Resectable Colorectal Carcinoma
Enrollment
150 pts
Location
United States
Sponsor
City of Hope Medical Center
NCT05944692 N/A
Recruiting
Epilepsy Seizure Detection With Innovative Tripolar EEG (tEEG)
Condition
Epilepsy
Enrollment
90 pts
Location
United States
Sponsor
CREmedical
NCT07419334 Phase 3
Recruiting
Study of ALK-001 on the Progression of Stargardt Disease
Condition
Stargardt Disease
Enrollment
230 pts
Location
United States
Sponsor
Alkeus Pharmaceuticals, Inc.
NCT06124157 Phase 2
Recruiting
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatme...
Condition
B Acute Lymphoblastic Leukemia
Enrollment
222 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
NCT05945329 N/A
Recruiting
Study of GalaFLEX LITE™ Scaffold in Treatment of Capsular Contracture After Brea...
Condition
Capsular Contracture Associated With Breast Implant
Enrollment
250 pts
Location
United States
Sponsor
C. R. Bard
NCT06989112 Phase 3
Recruiting
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegos...
Condition
Endometrial Cancer
Enrollment
600 pts
Location
United States, Australia, Austria
Sponsor
AstraZeneca
NCT07143019 N/A
Recruiting
The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked ...
Condition
Hemorrhagic Stroke
Enrollment
214 pts
Location
United States
Sponsor
phenox Inc.
NCT05836987 Phase 3
Recruiting
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial F...
Condition
Atrial Fibrillation
Enrollment
5,350 pts
Location
United States
Sponsor
Johns Hopkins University
NCT05495334 N/A
Recruiting
Innovations in Genicular Outcomes Registry
Condition
Knee Osteoarthritis
Enrollment
10,000 pts
Location
United States
Sponsor
Pacira Pharmaceuticals, Inc
NCT06872892 Phase 3
Recruiting
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With B...
Condition
Bronchiectasis
Enrollment
1,755 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology